4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-019463
Chief Business Officer acquired 37,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savill Corrine Chief Business Officer | 2024-02-22 | Grant or award | +37,500 | 203,490 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savill Corrine Chief Business Officer | 2024-02-22 | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…